Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

National Institute for Health and Care Excellence NICE logo

NICE backs two cancer drugs

Boehringer’s Giotrif and Janssen’s Velcade given final go-ahead for NHS use

- PMLiVE

Pfizer set to file Xeljanz for psoriasis

Set to add another indication after positive study results

- PMLiVE

Merck Serono CEO joins L’Oreal board

Belén Garijo named independent director at beauty company

- PMLiVE

Valeant offers $45.7bn for Botox firm Allergan

Trend for major pharma deals continues

- PMLiVE

Pfizer rumoured to be after AstraZeneca

Is this the return of the pharma mega-merger?

Novartis building

Novartis pays $16bn for GSK’s oncology portfolio

Swiss company strikes series of deals, including one to step away from vaccines

- PMLiVE

EMA warns on stolen Herceptin

Says vials of cancer drug have been tampered with and re-introduced into supply chain

- PMLiVE

Lilly’s stomach cancer drug cleared by FDA

Cyramza is tipped to reach blockbuster status depending on approvals

- PMLiVE

Number of healthcare professionals on Twitter tops 75,000

Doctors, nurses, pharmacists and consultants posting more than 152,000 tweets a day

- PMLiVE

Spectrum appoints Dr Dalna Harvey as regulatory project manager

She brings experience gained at firms such as Parexel, Chiron and Wyeth

- PMLiVE

Sex is a good trick

But pharma companies - and payers - should stop incestuous ‘best practice’ behaviours and look for new ways of comparing options

- PMLiVE

GSK corruption claims extend to Jordan and Lebanon

Follows bribery allegations in Poland, China and Iraq

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links